According to Zacks, “Surgery Partners, Inc. is a healthcare services company. The Company’s outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. “
Other equities analysts have also recently issued reports about the stock. Jefferies Group reaffirmed a buy rating and set a $27.00 price objective on shares of Surgery Partners in a research report on Wednesday, August 10th. Barclays PLC began coverage on Surgery Partners in a report on Wednesday, July 13th. They set an equal weight rating and a $20.00 target price for the company. Three research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of Buy and a consensus target price of $22.40.
Shares of Surgery Partners (NASDAQ:SGRY) opened at 20.07 on Wednesday. The company has a market cap of $974.00 million and a price-to-earnings ratio of 108.49. Surgery Partners has a one year low of $11.76 and a one year high of $22.32. The firm’s 50-day moving average is $19.48 and its 200-day moving average is $16.80.
Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Tuesday, August 9th. The company reported $0.16 EPS for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.02. Surgery Partners had a net margin of 2.63% and a return on equity of 18.80%. The firm earned $289.70 million during the quarter, compared to analysts’ expectations of $275.99 million. The firm’s revenue for the quarter was up 24.4% on a year-over-year basis. Analysts expect that Surgery Partners will post $0.63 EPS for the current fiscal year.
In related news, VP Jennifer Baldock sold 2,500 shares of the business’s stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $19.20, for a total value of $48,000.00. Following the completion of the transaction, the vice president now owns 66,983 shares of the company’s stock, valued at $1,286,073.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 7.10% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Metropolitan Life Insurance Co. NY increased its position in Surgery Partners by 0.9% in the second quarter. Metropolitan Life Insurance Co. NY now owns 18,008 shares of the company’s stock worth $322,000 after buying an additional 153 shares during the period. Royal Bank of Canada increased its position in Surgery Partners by 3.9% in the first quarter. Royal Bank of Canada now owns 9,634 shares of the company’s stock worth $129,000 after buying an additional 366 shares during the period. Schwab Charles Investment Management Inc. increased its position in Surgery Partners by 1.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 45,514 shares of the company’s stock worth $815,000 after buying an additional 630 shares during the period. BlackRock Inc. increased its position in Surgery Partners by 3.8% in the first quarter. BlackRock Inc. now owns 17,116 shares of the company’s stock worth $227,000 after buying an additional 632 shares during the period. Finally, American International Group Inc. increased its position in Surgery Partners by 19.7% in the second quarter. American International Group Inc. now owns 10,716 shares of the company’s stock worth $192,000 after buying an additional 1,766 shares during the period. 38.32% of the stock is owned by institutional investors and hedge funds.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.